MRVI Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. (MRVI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $127.5K.
Where they traded
Last open-market purchase: December 8, 2025 , by LUCIER GREGORY T .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| ORESHACK KURT | General Counsel | Sell 10b5-1 | 25,000 | $5.10 | $127.5K | 335,767 −6.9% of holding | |
| ORESHACK KURT | General Counsel | Sell 10b5-1 | 25,000 | $5.06 | $126.5K | 360,767 −6.5% of holding | |
| LUCIER GREGORY T | Director | Buy | 48,528 | $3.67 | $178.1K | 155,123 | |
| LUCIER GREGORY T | Director | Buy | 51,472 | $3.70 | $190.4K | 106,595 | |
| Brust Bernd | Chief Executive Officer | Buy | 216,212 | $3.25 | $702.7K | 466,771 | |
| Brust Bernd | Chief Executive Officer | Buy | 93,358 | $3.21 | $299.7K | 250,559 | |
| Brust Bernd | Chief Executive Officer | Buy | 157,201 | $3.24 | $509.3K | 157,201 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.